Latest News
- New treatment for early-stage lung cancer has Jami Way living the normal life she wants
Jami Way recites a mantra out loud before swallowing a pill each morning intended to prevent a return of lung cancer.
December 19, 2022 9:00 AM
detail - UCLA researchers receive grant from Prostate Cancer Foundation
The UCLA Ahmanson Translational Theranostics prostate cancer research group is part of a multi-institutional team that will receive a $10 million Prostate Cancer Foundation grant to develop new treatments for prostate cancer.
December 16, 2022 9:00 AM
detail - Dr. Jenny Tran exemplifies whole-person, culturally focused care at the heart of Simms/Mann cancer program
It is one thing to provide state-of-the-art medical care for those suffering from such a serious condition as cancer. But it is a whole extra challenge to make sure that this care is accessible to all groups, in a very diverse region of blended cultures and languages.
December 07, 2022 9:00 AM
detail - Unexpected weight loss leads to lung cancer diagnosis for non-smoker
Diana Wei was pretty happy when she lost 5 pounds without trying. But when her weight kept dropping, she mentioned the unexplained weight loss to her new doctor at UCLA Health.
December 06, 2022 10:00 AM
detail - CIRM grant will help expand patients’ access to innovative UCLA clinical trials
A five-year, $8 million grant from the California Institute for Regenerative Medicine will enable UCLA stem cell scientists to include a wider cross-section of Los Angeles’ diverse population in potentially lifesaving medical research.
October 28, 2022 12:00 PM
detail - UCLA post-doctoral scholar receives award to search for genetic clues to predict prostate cancer aggressiveness
Roni Haas has received the 2022 Todd Boehly-PCF Young Investigator Award from the Prostate Cancer Foundation to support her prostate cancer research project.
October 26, 2022 9:00 AM
detail - New analysis finds timing androgen-deprivation therapy with radiation therapy improves outcomes in localized prostate cancer
A new UCLA study shows that it is almost universally optimal for men to begin androgen deprivation therapy when starting radiation therapy for prostate cancer.
October 21, 2022 12:00 PM
detail - UCLA researchers identify a gene as a potential target in treatment-resistant brain cancer glioblastoma multiforme
Research led by UCLA doctors and scientists has identified a gene that may provide a therapeutic target for the deadly, treatment-resistant brain cancer glioblastoma multiforme (GBM).
October 20, 2022 10:00 AM
detail - Low blood phosphate levels may be linked to neurological side effects from CAR T-cell therapy
A new UCLA Health study finds a clue that could help reduce serious neurological side effects associated with CAR T-cell therapy known as immune effector cell-associated neurotoxicity syndrome (ICANS).
October 19, 2022 8:00 AM
detail - UCLA's Michael Grunstein wins 2022 Albany Prize for groundbreaking research
Michael Grunstein, distinguished professor emeritus of biological chemistry at the David Geffen School of Medicine at UCLA, has been awarded the 2022 Albany Prize for his groundbreaking research on gene expression.
October 13, 2022 10:00 AM
detail - Patient care goes hand in hand with clinical research for these gynecologic oncologists
Meet three UCLA gynecologic oncologists who are leading groundbreaking research aimed at the clinical challenges they encounter while providing direct patient care through every stage of treatment.
October 10, 2022 9:00 AM
detail - Long-term study supports link between inflammation and cognitive problems in older breast cancer survivors
A new long-term study of older breast cancer survivors published in the Journal of Clinical Oncology and co-led by UCLA researchers adds important evidence to that potential link.
September 29, 2022 1:00 PM
detail - UCLA Oncologist Receives 2022 Ellen Stovall Award
Dr. Patricia Ganz has been awarded the 2022 Ellen L. Stovall Award for Innovation in Patient-Centered Cancer Care.
September 29, 2022 9:00 AM
detail - Two early cancer detection programs boosted by renewed NCI grants
The National Cancer Institute has renewed funding for two collaborative programs through which UCLA Jonsson Comprehensive Cancer Center researchers are developing new biomarkers for earlier detection and more effective treatment of cancers.
September 26, 2022 9:00 AM
detail - Research led by UCLA’s Jonsson Comprehensive Cancer Center tests cost-effective approach to early-cancer detection from cell-free DNA in blood samples
UCLA researchers and collaborating organizations report successful results from an experimental cancer-detection system that appears to have overcome these challenges in a novel, cost-effective way.
September 23, 2022 10:00 AM
detail - Cell therapy could improve bone marrow transplant safety
UCLA researchers report a step forward in the development of an “off-the-shelf” cell therapy that could reduce the severity of graft-versus-host disease in people receiving donor bone marrow transplants for the treatment of blood cancers such as leukemia and lymphoma.
September 12, 2022 9:00 AM
detail - Antoni Ribas receives renewal of NCI Outstanding Investigator Award
Dr. Antoni Ribas has received a renewal of an Outstanding Investigator Award from the National Cancer Institute to fund his innovative research on metastatic melanoma.
September 07, 2022 9:00 AM
detail - UCLA Health organizes relief for Ukrainian cancer patients and refugees
This summer, UCLA Health sent two shipments of cancer drugs and supplies to Ukraine for patients desperately in need.
August 31, 2022 6:00 AM
detail - Colorectal cancer screening initiative from Stand Up to Cancer, collaborators wins Los Angeles Business Journal health care award
An ambitious joint initiative by Stand Up To Cancer® to improve colorectal cancer screening and treatment in medically underserved communities across Los Angeles was recognized today with a Health Care Leadership Award by the Los Angeles Business Journal.
August 31, 2022 6:00 AM
detail - Researchers examine link between pesticides and thyroid cancer risk in Central California area
In single pollutant models and within a 20-year period, 10 out of 29 reviewed pesticides were associated with thyroid cancer, including several of the most widely used ones in the U.S. These included paraquat dichloride, glyphosate and oxyfluorfen.
August 18, 2022 6:00 AM
detail